Nkarta to Participate in an Upcoming Investor Conference

Company Overview - Nkarta, Inc. is a clinical-stage biotechnology company focused on developing engineered natural killer (NK) cell therapies [2] - The company utilizes a combination of cell expansion, cryopreservation platforms, proprietary cell engineering technologies, and CRISPR-based genome engineering to advance its therapies [2] Upcoming Events - Nkarta will participate in the Stifel 2024 Healthcare Conference on November 19, 2024, at 10:55 a.m. ET, featuring a fireside chat [1] - A simultaneous webcast of the event will be available on Nkarta's website, with a replay archived for approximately 90 days [1]